Show Health and Fitness Publications

Tue, October 2, 2012

[ Tue, Oct 02nd 2012 ]: Market Wire

Newman Ferrara LLP Announces A Securities Fraud C .. Been Filed Against Questcor Pharmaceuticals, Inc.

[ Tue, Oct 02nd 2012 ]: Market Wire

Harwood Feffer LLP Announces Investigation of Peregrine Pharmaceuticals, Inc.

[ Tue, Oct 02nd 2012 ]: Market Wire

Albany Medical Center Standardizes to Masimo rainbow SET Pulse CO-Oximetry

[ Tue, Oct 02nd 2012 ]: Market Wire

GreeneStone Supports the Cause of Mental Health with Charitable Foundation

[ Tue, Oct 02nd 2012 ]: Market Wire

Aeterna Zentaris Presented Poster on Oral Prostat .. 120, at International Urology Conference in Japan

[ Tue, Oct 02nd 2012 ]: Market Wire

Milestone Scientific Receives China's SFDA Approval for STA System(R) Computer

[ Tue, Oct 02nd 2012 ]: Market Wire

RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum

[ Tue, Oct 02nd 2012 ]: Market Wire

NewLink to Present at 3rd Annual Cancer Immunotherapy Conference

[ Tue, Oct 02nd 2012 ]: Market Wire

LCA-Vision Reports Third Quarter 2012 Procedure Volume

[ Tue, Oct 02nd 2012 ]: Market Wire

Investigational New Drug Application Cleared for Omeros' Lead Compound in PDE10 Program

[ Tue, Oct 02nd 2012 ]: Market Wire

New Data Show no!no! Hair Dominates the Japanese Market for Women’s Hair Removal Devices

[ Tue, Oct 02nd 2012 ]: Market Wire

Antares Pharma Receives Development Milestone Payment

[ Tue, Oct 02nd 2012 ]: Market Wire

Biostar Pharmaceuticals, Inc. To Manufacture And .. ply Xijing Military Hospital With Three New Drugs

[ Tue, Oct 02nd 2012 ]: Market Wire

DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule

[ Tue, Oct 02nd 2012 ]: Market Wire

Studies assess linagliptin treatment in adults wi .. (T2D), as well as add-on to basal insulin therapy

[ Tue, Oct 02nd 2012 ]: Market Wire

Lilly and Boehringer Ingelheim Present Health Out .. for Investigational Novel Basal Insulin Analogue

[ Tue, Oct 02nd 2012 ]: Market Wire

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

[ Tue, Oct 02nd 2012 ]: Market Wire

Life Technologies establece un nuevo estndar mundial con el kit GlobalFilera" Express

[ Tue, Oct 02nd 2012 ]: Market Wire

Department of Justice Drops DaVita Inquiry

[ Tue, Oct 02nd 2012 ]: Market Wire

NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction

[ Tue, Oct 02nd 2012 ]: Market Wire

Medicure Announces Intention to Seek Expanded Aggrastat Label

Mon, October 1, 2012

[ Mon, Oct 01st 2012 ]: Market Wire

Law Offices of Howard G. Smith Announces Investigation of Questcor Pharmaceuticals, Inc.

[ Mon, Oct 01st 2012 ]: Market Wire

Perrigo Closes Acquisition Of Sergeant's Pet Care Products

[ Mon, Oct 01st 2012 ]: Market Wire

HealthSpring Unveils 2013 Medicare Advantage Plans with More Choices

[ Mon, Oct 01st 2012 ]: Market Wire

Luminex Corporation Participates in Community Initiatives to Save Lives

[ Mon, Oct 01st 2012 ]: Market Wire

Hamilton Medical Center Updates with Masimo Patient Monitoring Technologies

[ Mon, Oct 01st 2012 ]: Market Wire

Tenet Announces Four-Point Plan to Drive Shareholder Value Creation

[ Mon, Oct 01st 2012 ]: Market Wire

Extendicare Announces Exercise of Over-Allotment .. Closes on Lease of Remaining Two Kentucky Centers

[ Mon, Oct 01st 2012 ]: Market Wire

Care Improvement Plus Unveils 2013 Medicare Advantage Plans

[ Mon, Oct 01st 2012 ]: Market Wire

Where We Are Headed -- New Outlook on Hologic, Inc. and St. Jude Medical, Inc.

[ Mon, Oct 01st 2012 ]: Market Wire

XDx Appoints Peter Maag as President and CEO

[ Mon, Oct 01st 2012 ]: Market Wire

Horizon Pharma Announces Completion of Sales Force Expansion

[ Mon, Oct 01st 2012 ]: Market Wire

Implant Sciences Ships Explosives Trace Detectors .. to Protect Petroleum Infrastructure and Transport

[ Mon, Oct 01st 2012 ]: Market Wire

MethylGene Presents Clinical Data on MGCD265 at t .. Society for Medical Oncology (ESMO) 2012 Congress

[ Mon, Oct 01st 2012 ]: Market Wire

FONAR Reports Record Profits From Operations for .. me Doubles From Fiscal 2011;; Revenues Inc

[ Mon, Oct 01st 2012 ]: Market Wire

Bovie Medical to present at the 2012 SeeThruEquit .. p and Microcap Conference on Tuesday, October 2nd

[ Mon, Oct 01st 2012 ]: Market Wire

AVEO and Astellas Announce New Data Presented at .. ing the Safety and Tolerability Profile of Tivoza

[ Mon, Oct 01st 2012 ]: Market Wire

GTx Announces Sale of Fareston®;

[ Mon, Oct 01st 2012 ]: Market Wire

Syneron's elurea" Kicks Off the Break Up. Get Even! Campaign

[ Mon, Oct 01st 2012 ]: Market Wire

Sunshine Heart Announces Conditional Approval of .. E From the FDA for C-Pulse(R) Heart Assist System

[ Mon, Oct 01st 2012 ]: Market Wire

Millennium and Seattle Genetics Highlight Data fr .. imab Vedotin) Trial in Patients with Newly Diagno

[ Mon, Oct 01st 2012 ]: Market Wire

Could Stem Cells Hold the Key to Treating Traumatic Brain Injuries?

Sun, September 30, 2012

[ Sun, Sep 30th 2012 ]: Market Wire

Genomic Health anuncia la presentacin de tres estudios Oncotype DX sobre cncer de mama y colon

[ Sun, Sep 30th 2012 ]: Market Wire

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

[ Sun, Sep 30th 2012 ]: Market Wire

Threshold Pharmaceuticals Announces Preliminary D .. H-302 in Combination With Bevacizumab in Patients

[ Sun, Sep 30th 2012 ]: Market Wire

Interim Data for Cabozantinib 40 mg Dose Cohort i .. tant Prostate Cancer Presented at ESMO 2012 Congr

[ Sun, Sep 30th 2012 ]: Market Wire

Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012

Sat, September 29, 2012

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. tment-Naï;ve and Previously-Treated Metas

[ Sat, Sep 29th 2012 ]: Market Wire

Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. Treatment-Naï;;ve and Previously-Treat

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. in Treatment-Naï;;;ve and Previous

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. umab) in Treatment-Naï;;;;ve and

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. limumab) in Treatment-Naï;;;;;

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. (ipilimumab) in Treatment-Naï;;;;

[ Sat, Sep 29th 2012 ]: Market Wire

New Four- and Five-Year Survival Data for YERVOY& .. 59; (ipilimumab) in Treatment-Naï;;;

[ Sat, Sep 29th 2012 ]: Market Wire

ARIAD Presents Initial Clinical Proof-of-Concept .. Non-Small Cell Lung Cancer at ESMO 2012 Congress

[ Sat, Sep 29th 2012 ]: Market Wire

Updated Results from Phase 2b/3 GALAXY Trial Show .. vival from the Addition of Ganetespib to Docetaxe

[ Sat, Sep 29th 2012 ]: Market Wire

Exelixis Announces Data Presentation for GDC-0973 (XL518)

Fri, September 28, 2012